Hans Theodor Eich1,2, Kambiz Rahbar3,2, Sergiu Scobioala4,5, Christopher Kittel1,2, Heidi Wolters1,2, Sebastian Huss6,2, Khaled Elsayad1,2, Robert Seifert3,2, Lars Stegger3,2, Matthias Weckesser3,2, Uwe Haverkamp1,2. 1. Department of Radiation Oncology, University Hospital Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany. 2. West German Cancer Center, Muenster and Essen, Germany. 3. Department of Nuclear Medicine, University Hospital of Muenster, Muenster, Germany. 4. Department of Radiation Oncology, University Hospital Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany. sscobioala@yahoo.com. 5. West German Cancer Center, Muenster and Essen, Germany. sscobioala@yahoo.com. 6. Department of Pathology, University Hospital of Muenster, Muenster, Germany.
Abstract
OBJECTIVE: The objective of this study was to assess the accuracy of 68Ga-PSMA-11 PET/MRI, 18F-PSMA-1007 PET/CT, 68Ga-PSMA-11 PET/CT, and multiparametric (mp)MRI for the delineating of dominant intraprostatic lesions (IPL). MATERIALS AND METHODS: 35 patients with organ-confined prostate cancer who were assigned to definitive radiotherapy (RT) were divided into three groups based on imaging techniques: 68Ga-PSMA-PET/MRI (n = 9), 18F-PSMA-PET/CT (n = 16) and 68Ga-PSMA-PET/CT (n = 10). All patients without PSMA-PET/MRI received an additional mpMRI. PSMA-PET-based automatic isocontours and manual contours of the dominant IPLs were generated for each modality. The biopsy results were then used to validate whether any of the prostate biopsies were positive in the marked lesion using Dice similarity coefficient (DSC), Youden index (YI), sensitivity and specificity. Factors that can predict the accuracy of IPLs contouring were analysed. RESULTS: Diagnostic performance was significantly superior both for manual and automatic IPLs contouring using 68Ga-PSMA-PET/MRI (DSC/YI SUV70%-0.62/0.51), 18F-PSMA-PET/CT (DSC/YI SUV70%-0.67/0.53) or 68Ga-PSMA-PET/CT (DSC/YI SUV70%-0.63/0.51) compared to mpMRI (DSC/YI-0.47/0.41; p < 0.001). The accuracy for delineating IPLs was not improved by combination of PET/CT and mpMRI images compared to PET/CT alone. Significantly superior diagnostic accuracy was found for large prostate lesions (at least 15% from the prostate volume) and higher Gleason score (at least 7b) comparing to smaller lesions with lower GS. CONCLUSION: IPL localization was significantly improved when using PSMA-imaging procedures compared to mpMRI. No significant difference for delineating IPLs was found between hybrid method PSMA-PET/MRI and PSMA-PET/CT. PSMA-based imaging technique should be considered for the diagnostics of IPLs and focal treatment modality.
OBJECTIVE: The objective of this study was to assess the accuracy of 68Ga-PSMA-11 PET/MRI, 18F-PSMA-1007 PET/CT, 68Ga-PSMA-11 PET/CT, and multiparametric (mp)MRI for the delineating of dominant intraprostatic lesions (IPL). MATERIALS AND METHODS: 35 patients with organ-confined prostate cancer who were assigned to definitive radiotherapy (RT) were divided into three groups based on imaging techniques: 68Ga-PSMA-PET/MRI (n = 9), 18F-PSMA-PET/CT (n = 16) and 68Ga-PSMA-PET/CT (n = 10). All patients without PSMA-PET/MRI received an additional mpMRI. PSMA-PET-based automatic isocontours and manual contours of the dominant IPLs were generated for each modality. The biopsy results were then used to validate whether any of the prostate biopsies were positive in the marked lesion using Dice similarity coefficient (DSC), Youden index (YI), sensitivity and specificity. Factors that can predict the accuracy of IPLs contouring were analysed. RESULTS: Diagnostic performance was significantly superior both for manual and automatic IPLs contouring using 68Ga-PSMA-PET/MRI (DSC/YI SUV70%-0.62/0.51), 18F-PSMA-PET/CT (DSC/YI SUV70%-0.67/0.53) or 68Ga-PSMA-PET/CT (DSC/YI SUV70%-0.63/0.51) compared to mpMRI (DSC/YI-0.47/0.41; p < 0.001). The accuracy for delineating IPLs was not improved by combination of PET/CT and mpMRI images compared to PET/CT alone. Significantly superior diagnostic accuracy was found for large prostate lesions (at least 15% from the prostate volume) and higher Gleason score (at least 7b) comparing to smaller lesions with lower GS. CONCLUSION: IPL localization was significantly improved when using PSMA-imaging procedures compared to mpMRI. No significant difference for delineating IPLs was found between hybrid method PSMA-PET/MRI and PSMA-PET/CT. PSMA-based imaging technique should be considered for the diagnostics of IPLs and focal treatment modality.
Entities:
Keywords:
Biopsy-derived landmarks; Hybrid imaging; Multiparametric MRI; PSMA-PET; Prostate cancer
Authors: Laura Van den Bergh; Michel Koole; Sofie Isebaert; Steven Joniau; Christophe M Deroose; Raymond Oyen; Evelyne Lerut; Tom Budiharto; Felix Mottaghy; Guy Bormans; Hendrik Van Poppel; Karin Haustermans Journal: Int J Radiat Oncol Biol Phys Date: 2012-01-26 Impact factor: 7.038
Authors: Simona Malaspina; Ugo De Giorgi; Jukka Kemppainen; Angelo Del Sole; Giovanni Paganelli Journal: Radiol Med Date: 2018-08-16 Impact factor: 3.469
Authors: Claudia Kesch; Maria Vinsensia; Jan P Radtke; Heinz P Schlemmer; Martina Heller; Elena Ellert; Tim Holland-Letz; Stefan Duensing; Nils Grabe; Ali Afshar-Oromieh; Kathrin Wieczorek; Martin Schäfer; Oliver C Neels; Jens Cardinale; Clemens Kratochwil; Markus Hohenfellner; Klaus Kopka; Uwe Haberkorn; Boris A Hadaschik; Frederik L Giesel Journal: J Nucl Med Date: 2017-05-04 Impact factor: 10.057
Authors: Joe H Chang; Daryl Lim Joon; Ian D Davis; Sze Ting Lee; Chee-Yan Hiew; Stephen Esler; Sylvia J Gong; Morikatsu Wada; David Clouston; Richard O'Sullivan; Yin P Goh; Damien Bolton; Andrew M Scott; Vincent Khoo Journal: Int J Radiat Oncol Biol Phys Date: 2015-04-08 Impact factor: 7.038
Authors: Laura Evangelista; Alberto Briganti; Stefano Fanti; Stephen Joniau; Sven Reske; Riccardo Schiavina; Christian Stief; George N Thalmann; Maria Picchio Journal: Eur Urol Date: 2016-02-02 Impact factor: 20.096
Authors: Alisa S Bettermann; Constantinos Zamboglou; Selina Kiefer; Cordula A Jilg; Simon Spohn; Jasmin Kranz-Rudolph; Thomas F Fassbender; Peter Bronsert; Nils H Nicolay; Christian Gratzke; Michael Bock; Juri Ruf; Matthias Benndorf; Anca L Grosu Journal: Radiother Oncol Date: 2019-08-17 Impact factor: 6.280
Authors: Constantinos Zamboglou; Thomas F Fassbender; Lina Steffan; Florian Schiller; Tobias Fechter; Montserrat Carles; Selina Kiefer; Hans C Rischke; Kathrin Reichel; Nina-Sophie Schmidt-Hegemann; Harun Ilhan; Alin F Chirindel; Guillaume Nicolas; Christoph Henkenberens; Thorsten Derlin; Peter Bronsert; Panayiotis Mavroidis; Ronald C Chen; Philipp T Meyer; Juri Ruf; Anca L Grosu Journal: Radiother Oncol Date: 2019-08-17 Impact factor: 6.280
Authors: Mathieu Gaudreault; David Chang; Nicholas Hardcastle; Price Jackson; Tomas Kron; Michael S Hofman; Shankar Siva Journal: Clin Transl Radiat Oncol Date: 2022-05-17